Observational Study of Endoscopic Submucosal Dissection (ESD)
This study is looking at a procedure called Endoscopic Submucosal Dissection (ESD). ESD is a way to remove deep growths or lesions from your gastrointestinal (GI) tract, which includes areas like your esophagus (food pipe). This procedure is done as an outpatient, meaning you don't stay overnight in the hospital. The study aims to see how well ESD works for treating lesions in the GI tract, including those related to Barrett Esophagus. You can join if you are 18 or older and are already scheduled to have an ESD procedure. The study will follow your progress for 12 months to see the results. This is an observational study, meaning you will receive standard medical care, and no experimental treatments are involved. The study is currently unclear about its recruitment status and plans to enroll 1000 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information about patients undergoing a standard medical procedure. There is no specified phase for this study, and it plans to enroll 1000 participants.
- What's involved
- You would be participating if you are already scheduled to undergo Endoscopic Submucosal Dissection (ESD). All patients will receive standard medical care.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will evaluate the utility of ESD for treatment of gastrointestinal lesions at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Endoscopic Submucosal Dissection (ESD)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Dennis Yang, MD · PRINCIPAL_INVESTIGATOR · AdventHealth Orlando
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluate the utility of ESD for treatment of gastrointestinal lesions12 months
The primary endpoint of this study will be the prospective evaluation of the utility of ESD for the endoscopic treatment of GI lesions.